Welcome to eBioscience. Tel: 888.999.1371 or 858.642.2058.  San Diego, California, USA.
View cart
Account
Ordering help
MSDS
Home Products Protocols Technical Support About Us Contact Us

Biotin anti-human TWEAK

 
Print Page 
 
Adobe PDF    Human Cellular Antigens Chart
Contents: Biotin anti-human TWEAK
Catalog Number: 13-9915
Formulation: Phosphate buffer pH 7.2,
500 mM NaCl, 0.09% NaN3
Storage Conditions: Store at 4°C.
DO NOT FREEZE.
Clone: CARL-1
Isotype: Mouse IgG3, κ

Product OptionsPrice
Cat. No.Size

To view relevant pricing,
please select your country
and resume browsing.

13-9915-80 25 ug
13-9915-82 100 ug


   
data image 1
Staining of human TWEAK-transfected cells with 0.5 μg of Iso Cntrl (open histogram) or 0.5 μg of Biotin anti-human TWEAK (CARL-1) (colored histogram) followed by SAv-PE (cat. 12-4317). Total viable cells were used for analysis.
Available Formats of This Product
Cat. No. Format Excite
(nm)
Emit
(nm)
Reported Applications
14-9915 Affinity Purified anti-human TWEAK N/A N/A FA  FC 
16-9915 Functional Grade* Purified anti-human TWEAK N/A N/A FA  FC 
13-9915 Biotin anti-human TWEAK N/A N/A ELISA det  FC 
12-9915 PE anti-human TWEAK 488 575 FC 
*Functional Grade™ (FG™) Purified: Azide-free, sterile-filtered, and endotoxin < 0.001 ng/µg  (unless otherwise noted).
*Functional Grade™ (FG™) Biotin: Azide-free, sterile-filtered, and endotoxin < 0.05 ng/µg.
  Purified: Contains azide, not sterile-filtered, and not endotoxin tested.
Flow Cytometry Product Notes:
Test Sizes: To accommodate multicolor flow cytometry, eBioscience is in the process of reducing test size volumes from 20 µl to 5 µl. Please check your antibody vial for the recommended test size.
Fluorochrome Replacements: eBioscience is in the process of replacing all Pacific Blue® and APC-Alexa Fluor® 750 conjugated products with eFluor™ 450 and APC-eFluor™ 780 conjugated products, respectively.

Custom Product Requests
Need a custom product? Download the Custom Product Request Form and submit completed form to customs@ebioscience.com.

Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq.


Description


The CARL-1 monoclonal antibody reacts with human TWEAK, a type II transmembrane TNF superfamily member with high identity to TNF in its extracellular portion. TWEAK transcript is expressed broadly in many adult and fetal tissues, however, the staining of human peripheral blood mononuclear cells with monoclonal antibodies shows a more restricted pattern. While freshly isolated PBMCs do not express detectable levels of TWEAK on their surface, IFN-γ-stimulated blood monocytes rapidly upregulate TWEAK surface expression. TWEAK is expressed as membrane bound and secreted forms. Interaction of TWEAK with its counter-receptor promotes secretion of IL-8, activation of NF-κB, proliferation of endothelial cells, and apoptosis in a number of human cell lines. Initially, DR3 was thought to be a receptor for TWEAK, but further studies have shown that TWEAK could induce apoptosis via receptors distinct from DR3. While TWEAK exhibits overlapping signaling functions to TNF, it is generally less effective in inducing apoptosis, giving rise to its name, TNF-like weak inducer of apoptosis. For detection of human TWEAK by sandwich ELISA, a combination of purified CARL-2 for capture and biotinylated CARL-1 for detection is recommended.


Applications Reported


For research use only, not for diagnostic or therapeutic use. The CARL-1 antibody has been reported for use in flow cytometric analysis, and ELISA.


Applications Tested


The CARL-1 antibody has been tested by flow cytometric analysis of transfected cells and IFN-γ-stimulated human PBMCs. This can be used at less than or equal to 1 μg per 100 μl blood (or per 1 million cells in 100 μl total staining volume). It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.


References



Nakayama, M., N. Kayagaki, et al. (2000). "Involvement of TWEAK in Interferon {gamma}-stimulated Monocyte Cytotoxicity." J. Exp. Med. 192(9): 1373-1380.
Chicheportiche, Y., P. R. Bourdon, et al. (1997). "TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis." J Biol Chem 272(51): 32401-10.
Kaplan, M. J., D. Ray, et al. (2000). "TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages [In Process Citation]." J Immunol 164(6): 2897-904.
Lynch, C. N., Y. C. Wang, et al. (1999). "TWEAK induces angiogenesis and proliferation of endothelial cells." J Biol Chem 274(13): 8455-9.
Schneider, P., R. Schwenzer, et al. (1999). "TWEAK can induce cell death via endogenous TNF and TNF receptor 1." Eur J Immunol 29(6): 1785-92.


Related Products


Cat. 00-0000  eBioscience 10X ELISA Coating Buffer
Cat. 44-2404  Nunc MaxiSorp™ flat-bottom 96 well plate
Cat. 18-4100  Avidin Horse Radish Peroxidase (AV-HRP)
Cat. 00-4202  eBioscience ELISA Diluent Solution, 5X
Cat. 00-4203  Super AquaBlue ELISA Substrate
Cat. 11-4317  Streptavidin-FITC (Fluorescein isothiocyanate)
Cat. 12-4317  Streptavidin-PE (Phycoerythrin)
Cat. 17-4317  Streptavidin Allophycocyanin (SA-APC)
Cat. 14-8916  Recombinant Human TWEAK
Cat. 14-9916  Affinity Purified anti-human TWEAK (clone CARL-2)


Home  |   Index  |   Site Map  |   FAQ  |   Terms & Conditions  |   Distributors  |   Careers  |   Contact Us
Copyright © 2000-2009 eBioscience, Inc.
For Research Use Only. Not for use in diagnostic procedures. Not for further distribution without written consent.